Read Time:6 Second
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Average Rating
More Stories
NBA Games for 2/21/2025
WWE Smackdown Results for 2/21/2025
NBA Transactions for 2/15-21/2025